Porth's Essentials of Pathophysiology, 4e

485

Disorders of Cardiac Function

C h a p t e r 1 9

81. Sachdeva R. Atrial septal defects. In: Allen HD, Driscoll DJ, Shaddy RE, et al., eds. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents , vol. I, 8th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2013:672. 82. Rubio AE, Lewin MB. Ventricular septal defects. In: Allen HD, Driscoll DJ, Shaddy RE, et al., eds. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents , vol. I, 8th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2013:713. 83. Cetta F, Minich LL, Maleszewski JJ, et al. Atrioventricular septal defects. In: Allen HD, Driscoll DJ, Shaddy RE, et al., eds. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents , vol. I, 8th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2013:691. 84. Prieto LR, Latson LA. Pulmonary stenosis. In: Allen HD, Driscoll DJ, Shaddy RE, et al., eds. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents , vol. II, 8th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2013:913–938. 85. McCrindle BW. Prevalence of congenital cardiac disease. In: Anderson R, Baker E, Penny D, et al., eds. Paediatric Cardiology . 3rd ed. Philadelphia, PA: Churchill Livingstone/Elsevier; 2010:143–160. 86. Roche SL, Greenway SC, Redington AN. Tetralogy of fallot with pulmonary stenosis and tetralogy of fallot with absent pulmonary valve. In: Allen HD, Driscoll DJ, Shaddy RE, et al., eds. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents , vol. II, 8th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2013:969. 87. Wernovsky G. Transposition of the great arteries. In: Allen HD, Driscoll DJ, Shaddy RE, et al., eds. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents , vol. II, 8th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2013:1097. 88. Beekman RH. Coarctation of the aorta. In: Allen HD, Driscoll DJ, Shaddy RE, et al., eds. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents , vol. II, 8th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2013:1044–1060. 89. Wernovsky G, Dominguez TE, Gruber PJ, et al. Hypoplasia of the left heart. In: Anderson R, Baker E, Penny D, et al., eds. Paediatric Cardiology . 3rd ed. Philadelphia, PA: Churchill Livingstone/Elsevier; 2010:625–646. 90. Daubeney PEF. Hypoplasia of the right ventricle. In: Anderson R, Baker E, Penny D, et al., eds. Paediatric Cardiology . 3rd ed. Philadelphia, PA: Churchill Livingstone/Elsevier; 2010:647–664. 91. Penny DJ, Anderson RH. Other forms of functionally univentricular hearts. In: Anderson R, Baker E, Penny D, et al.,

eds. Paediatric Cardiology . 3rd ed. Philadelphia, PA: Churchill Livingstone/Elsevier; 2010:665–686. 92. Tweddell JS, Hoffman GM, Ghanayem NS, et al. Hypoplastic left heart syndrome. In: Allen HD, Driscoll DJ, Shaddy RE, et al., eds. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents , vol. II, 8th ed. Philadelphia, PA: Wolters Kluwer Health | Lippincott Williams & Wilkins; 2013:1061–1096. 93. Hutter D, Redington AN. The principles of management, and outcomes for, patients with functionally univentricular hearts. In: Anderson R, Baker E, Penny D, et al., eds. Paediatric Cardiology . 3rd ed. Philadelphia, PA: Churchill Livingstone/Elsevier; 2010:687–696. 94. Bayers S, Shulman ST, Paller AS. Kawasaki disease: Part I. Diagnosis, clinical features, and pathogenesis. J Am Acad Dermatol. 2013;69(4):501.e1–501.e11; quiz 511–512. 95. De Ferranti SD, Newburger JW. Kawasaki disease (mucocutaneous lymph node syndrome). In: Allen HD, Driscoll DJ, Shaddy RE, et al., eds. Moss and Adams’ Heart Disease in Infants, Children, and Adolescents , vol. II, 8th ed. Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2013:1287–1302. 96. Lue HC, Chen LR, Lin MT, et al. Epidemiological features of Kawasaki disease in Taiwan, 1976–2007: results of five nationwide questionnaire hospital surveys. Pediatr Neonatol . 2013;55(2):93–96. 97. Bayers S, Shulman ST, Paller AS. Kawasaki disease: Part II. Complications and treatment. J Am Acad Dermatol . 2013;69(4):513.e1–513.e8; quiz 521–522. 98. Newburger JW, Takahashi M, Gerber MA, et al., Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics . 2004;114(6):1708–1733.

Porth Essentials Resources Explore these additional resources to enhance learning for this chapter: •  NCLEX-Style Questions and Other Resources

on

, http://thePoint.lww.com/PorthEssentials4e

•  Study Guide for Essentials of Pathophysiology •  Adaptive Learning | Powered by PrepU, http://thepoint.lww.com/ prepu